Adooq Bioscience
INCB28060, a novel inhibitor of c-MET kinase. INCB28060 exhibits picomolar enzymatic potency and is highly specific for c-MET with more than 10,000-fold selectivity over a large panel of human kinases. This inhibitor potently blocks c-MET phosphorylation and activation of its key downstream effectors in c-MET-dependent tumor cell lines.
More Information
Supplier Page
MPC-3100 50mg
50mg
| Purity Not Available
Adooq Bioscience
MPC-3100 is an orally bioavailable, synthetic, second-generation small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity.
More Information
Supplier Page
MPC-3100 5mg
5mg
| Purity Not Available
Adooq Bioscience
MPC-3100 is an orally bioavailable, synthetic, second-generation small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity.
More Information
Supplier Page
MPC-3100 100mg
100mg
| Purity Not Available
Adooq Bioscience
MPC-3100 is an orally bioavailable, synthetic, second-generation small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity.
More Information
Supplier Page
LY2109761 5mg
5mg
| Purity Not Available
Adooq Bioscience
LY2109761, a novel transforming growth factor ?? receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
More Information
Supplier Page
Adooq Bioscience
LY2109761, a novel transforming growth factor ?? receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
More Information
Supplier Page
INCB8761 10mg
10mg
| Purity Not Available
Adooq Bioscience
MK-2048 50mg
50mg
| Purity Not Available
Adooq Bioscience
MK-2048 5mg
5mg
| Purity Not Available
Adooq Bioscience
MK-2048 100mg
100mg
| Purity Not Available
Adooq Bioscience